| Mr Joshua Anthony Goins, PHARMD | |
|
1610 Church St, Conway, SC 29526-2930 | |
| (843) 248-0505 | |
| Not Available |
| Full Name | Mr Joshua Anthony Goins |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1610 Church St, Conway, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922436617 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14159 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Joshua Anthony Goins, PHARMD 1610 Church St, Conway, SC 29526-2930 Ph: (843) 248-0505 | Mr Joshua Anthony Goins, PHARMD 1610 Church St, Conway, SC 29526-2930 Ph: (843) 248-0505 |
News Archive
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor (JAK inhibitor) can achieve success either cycling to other JAKi medications or switching to a biologic drug.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system - sometimes dampening it, other times stimulating it. This newly identified partner not only sheds light on the inner workings of the immune system in diseases such as HIV, autoimmunity, and cancer, but also provides a critical path toward the development of novel treatments that target TIM-3.
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
› Verified 5 days ago
Matthew Bradford Combs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 10th Ave, Conway, SC 29526 Phone: 843-248-5015 Fax: 843-488-1942 | |
Roy Mcclanahan Iii, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 707 Church St, Conway, SC 29526 Phone: 843-248-6302 | |
Dr. Julie Bowers Strickland, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2219 Main St, Conway, SC 29526 Phone: 843-488-4400 | |
Mrs. Tonya Lynn Todd, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1401 Main St, Conway, SC 29526 Phone: 843-248-4609 Fax: 843-488-0770 | |
Mr. John Michael Coffman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2709 Church St Ste A, Conway, SC 29526 Phone: 843-365-0301 Fax: 843-375-0318 | |
Mr. Joseph Hamilton Odom, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1608 Main St, Conway, SC 29526 Phone: 843-248-4700 Fax: 843-488-6346 | |
Mary Margaret Zeller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 707 Church St, Conway, SC 29526 Phone: 843-248-6302 |